Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Lung Neoplasms 1Disease 1Diabetes Mellitus, Type 2 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Blood Specimen Collection 6pembrolizumab 2fluciclovine F-18 2Surveys and Questionnaires 2Preoperative Exercise 2Magnetic Resonance Imaging 2Exercise 2Cryosurgery 2Bevacizumab 2tislelizumab 1neratinib 1imetelstat 1daratumumab 1atezolizumab 1abiraterone 1Waiting Lists 1Videotape Recording 1Urine Specimen Collection 1Triamcinolone Acetonide 1Transcutaneous Electric Nerve Stimulation 1Tomography, X-Ray Computed 1Thoracic Surgical Procedures 1TIC10 compound 1Sulfonylurea Compounds 1Standard of Care 1Specimen Handling 1Sodium-Glucose Transporter 2 Inhibitors 1Serologic Tests 1Sequence Analysis, RNA 1S-Adenosylmethionine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Disease × Dipeptidyl-Peptidase IV Inhibitors × 1 year × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡